Jan 28, 2021 · 41m · we-live-to-build

The Patent Pending Secret That Adds $1M to Your Startup Valuation

Dr. Devorah Grazer · 32m spoken Sean Weisbrot · 5m spoken
0:00 / 0:00
▶ Watch on YouTube →

gold bands on the timeline = statements, start to end. Hover to read, click to jump. CC turns on captions

In this episode of the 'We Live to Build' podcast, host Sean Weisbrot interviews patent agent Dr. Devorah Grazer on how early-stage startups can strategically leverage intellectual property, navigate USPTO filing procedures, boost enterprise valuation, and adapt to emerging technologies like AI.

How this conversation actually went

Every chapter scored 0–10 on four independent dynamics. Hover any point for the reasoning behind the score. Sean holds 16.1% of the talking time here. How this is scored →

Sean as informed peer 2.1 Guest teaching 6.1 Guest disagreement 0.3 Sean pushing back 0.1
05100:0015:0030:001:24–4:52 · Sean as informed peer 2/10 We Live to Build Show Bumper and Mission Statement Sean introduces the podcast and asks Dr. Grazer about her background and the outcome of the Human Genome Project patent battles. Dr. Grazer explains how courts determined pure genetic material is unpatentable, educating Sean on biological IP law.4:53–7:38 · Sean as informed peer 1/10 Defining Patents: Legal Monopolies, History, and Disclosure Requirements Sean asks foundational questions regarding what patents are and what types exist. Dr. Grazer delivers an informative breakdown of legal monopolies, historical guild secrecy, and utility versus design patents.7:38–12:53 · Sean as informed peer 1/10 The Territorial Nature of Global Patents Sean inquires why there is no single international patent office and what the US filing workflow entails. Dr. Grazer walks through the territorial nature of patent treaties, patentability searches, claim drafting, and USPTO examiner negotiations.12:54–15:59 · Sean as informed peer 2/10 DIY Filing vs. Professional Patent Agents: Costs, Risks, and Timelines Sean asks about the cost and timeline differences between self-filing and hiring a registered agent or attorney. Dr. Grazer highlights the precision of legal language, provisional applications, and the major financial and validity risks of DIY filing mistakes.15:59–19:10 · Sean as informed peer 2/10 USPTO Examination Backlogs and Claim Strategy Sean asks about examination wait times and the pros and cons of patenting for startups. Dr. Grazer explains USPTO backlogs, uses a property fence analogy for claim scope, and notes that a pending patent application typically adds one million dollars to a startup valuation.19:11–21:59 · Sean as informed peer 2/10 Strategic Business Applications of Patents and Channel Sales Defense Sean prompts Dr. Grazer to explain commercial drawbacks and optimal filing timelines. Dr. Grazer clarifies that US law offers a one-year post-publication grace period, whereas international jurisdictions require absolute novelty prior to public disclosure.21:59–25:22 · Sean as informed peer 2/10 Understanding Patent Trolls, Non-Practicing Entities, and Injunction Limits Sean asks Dr. Grazer to define patent trolls and asks what key topics founders overlook. Dr. Grazer breaks down non-practicing entities and preliminary injunction legal standards, emphasizing why early proactive IP planning is critical.25:23–27:51 · Sean as informed peer 2/10 KISS Platform and Agile Competitive Intelligence with iSearch.ai Sean asks about the unique selling proposition of Dr. Grazer's software tool iSearch.ai and KISS Platform. Dr. Grazer describes how the platform democratizes agile competitive intelligence and patent analysis for early-stage innovators.27:51–30:57 · Sean as informed peer 3/10 Future of Intellectual Property: Patent Pools and FRAND Licensing Sean connects historical government origins with rapid modern technological shifts under Industry 4.0. Dr. Grazer responds by illustrating how modern patent pools and telecommunications FRAND licensing prevent market monopolization.30:57–32:57 · Sean as informed peer 3/10 Open Source, Defensive Patent Pledges, and Industry Non-Aggression Sean asks if any industry has collectively boycotted patents. Dr. Grazer explains that while open-source licensing and corporate pledges like Tesla and Twitter exist, complete industry-wide non-aggression pacts remain largely non-existent.32:58–36:33 · Sean as informed peer 3/10 Artificial Intelligence in Patent Law: Authorship, Inventorship, and Ethics Sean inquires whether AI must be deemed sentient to own patents, to which Dr. Grazer cites legal precedent from the monkey selfie case restricting inventorship to humans. Sean playfully objects to human-exclusive copyright frameworks.36:33–39:46 · Sean as informed peer 2/10 The Fundamentals of Patent Licensing and Business Agreements Sean asks about the mechanics of patent licensing and recent business lessons. Dr. Grazer clarifies that licensing agreements are commercial contracts governed by overarching business goals, sharing how COVID forced agile operational pivots.1:24–4:52 · Guest teaching 5/10 We Live to Build Show Bumper and Mission Statement Sean introduces the podcast and asks Dr. Grazer about her background and the outcome of the Human Genome Project patent battles. Dr. Grazer explains how courts determined pure genetic material is unpatentable, educating Sean on biological IP law.4:53–7:38 · Guest teaching 6/10 Defining Patents: Legal Monopolies, History, and Disclosure Requirements Sean asks foundational questions regarding what patents are and what types exist. Dr. Grazer delivers an informative breakdown of legal monopolies, historical guild secrecy, and utility versus design patents.7:38–12:53 · Guest teaching 7/10 The Territorial Nature of Global Patents Sean inquires why there is no single international patent office and what the US filing workflow entails. Dr. Grazer walks through the territorial nature of patent treaties, patentability searches, claim drafting, and USPTO examiner negotiations.12:54–15:59 · Guest teaching 7/10 DIY Filing vs. Professional Patent Agents: Costs, Risks, and Timelines Sean asks about the cost and timeline differences between self-filing and hiring a registered agent or attorney. Dr. Grazer highlights the precision of legal language, provisional applications, and the major financial and validity risks of DIY filing mistakes.15:59–19:10 · Guest teaching 7/10 USPTO Examination Backlogs and Claim Strategy Sean asks about examination wait times and the pros and cons of patenting for startups. Dr. Grazer explains USPTO backlogs, uses a property fence analogy for claim scope, and notes that a pending patent application typically adds one million dollars to a startup valuation.19:11–21:59 · Guest teaching 7/10 Strategic Business Applications of Patents and Channel Sales Defense Sean prompts Dr. Grazer to explain commercial drawbacks and optimal filing timelines. Dr. Grazer clarifies that US law offers a one-year post-publication grace period, whereas international jurisdictions require absolute novelty prior to public disclosure.21:59–25:22 · Guest teaching 6/10 Understanding Patent Trolls, Non-Practicing Entities, and Injunction Limits Sean asks Dr. Grazer to define patent trolls and asks what key topics founders overlook. Dr. Grazer breaks down non-practicing entities and preliminary injunction legal standards, emphasizing why early proactive IP planning is critical.25:23–27:51 · Guest teaching 4/10 KISS Platform and Agile Competitive Intelligence with iSearch.ai Sean asks about the unique selling proposition of Dr. Grazer's software tool iSearch.ai and KISS Platform. Dr. Grazer describes how the platform democratizes agile competitive intelligence and patent analysis for early-stage innovators.27:51–30:57 · Guest teaching 7/10 Future of Intellectual Property: Patent Pools and FRAND Licensing Sean connects historical government origins with rapid modern technological shifts under Industry 4.0. Dr. Grazer responds by illustrating how modern patent pools and telecommunications FRAND licensing prevent market monopolization.30:57–32:57 · Guest teaching 6/10 Open Source, Defensive Patent Pledges, and Industry Non-Aggression Sean asks if any industry has collectively boycotted patents. Dr. Grazer explains that while open-source licensing and corporate pledges like Tesla and Twitter exist, complete industry-wide non-aggression pacts remain largely non-existent.32:58–36:33 · Guest teaching 6/10 Artificial Intelligence in Patent Law: Authorship, Inventorship, and Ethics Sean inquires whether AI must be deemed sentient to own patents, to which Dr. Grazer cites legal precedent from the monkey selfie case restricting inventorship to humans. Sean playfully objects to human-exclusive copyright frameworks.36:33–39:46 · Guest teaching 5/10 The Fundamentals of Patent Licensing and Business Agreements Sean asks about the mechanics of patent licensing and recent business lessons. Dr. Grazer clarifies that licensing agreements are commercial contracts governed by overarching business goals, sharing how COVID forced agile operational pivots.1:24–4:52 · Guest disagreement 1/10 We Live to Build Show Bumper and Mission Statement Sean introduces the podcast and asks Dr. Grazer about her background and the outcome of the Human Genome Project patent battles. Dr. Grazer explains how courts determined pure genetic material is unpatentable, educating Sean on biological IP law.4:53–7:38 · Guest disagreement 0/10 Defining Patents: Legal Monopolies, History, and Disclosure Requirements Sean asks foundational questions regarding what patents are and what types exist. Dr. Grazer delivers an informative breakdown of legal monopolies, historical guild secrecy, and utility versus design patents.7:38–12:53 · Guest disagreement 0/10 The Territorial Nature of Global Patents Sean inquires why there is no single international patent office and what the US filing workflow entails. Dr. Grazer walks through the territorial nature of patent treaties, patentability searches, claim drafting, and USPTO examiner negotiations.12:54–15:59 · Guest disagreement 0/10 DIY Filing vs. Professional Patent Agents: Costs, Risks, and Timelines Sean asks about the cost and timeline differences between self-filing and hiring a registered agent or attorney. Dr. Grazer highlights the precision of legal language, provisional applications, and the major financial and validity risks of DIY filing mistakes.15:59–19:10 · Guest disagreement 0/10 USPTO Examination Backlogs and Claim Strategy Sean asks about examination wait times and the pros and cons of patenting for startups. Dr. Grazer explains USPTO backlogs, uses a property fence analogy for claim scope, and notes that a pending patent application typically adds one million dollars to a startup valuation.19:11–21:59 · Guest disagreement 0/10 Strategic Business Applications of Patents and Channel Sales Defense Sean prompts Dr. Grazer to explain commercial drawbacks and optimal filing timelines. Dr. Grazer clarifies that US law offers a one-year post-publication grace period, whereas international jurisdictions require absolute novelty prior to public disclosure.21:59–25:22 · Guest disagreement 0/10 Understanding Patent Trolls, Non-Practicing Entities, and Injunction Limits Sean asks Dr. Grazer to define patent trolls and asks what key topics founders overlook. Dr. Grazer breaks down non-practicing entities and preliminary injunction legal standards, emphasizing why early proactive IP planning is critical.25:23–27:51 · Guest disagreement 0/10 KISS Platform and Agile Competitive Intelligence with iSearch.ai Sean asks about the unique selling proposition of Dr. Grazer's software tool iSearch.ai and KISS Platform. Dr. Grazer describes how the platform democratizes agile competitive intelligence and patent analysis for early-stage innovators.27:51–30:57 · Guest disagreement 0/10 Future of Intellectual Property: Patent Pools and FRAND Licensing Sean connects historical government origins with rapid modern technological shifts under Industry 4.0. Dr. Grazer responds by illustrating how modern patent pools and telecommunications FRAND licensing prevent market monopolization.30:57–32:57 · Guest disagreement 1/10 Open Source, Defensive Patent Pledges, and Industry Non-Aggression Sean asks if any industry has collectively boycotted patents. Dr. Grazer explains that while open-source licensing and corporate pledges like Tesla and Twitter exist, complete industry-wide non-aggression pacts remain largely non-existent.32:58–36:33 · Guest disagreement 1/10 Artificial Intelligence in Patent Law: Authorship, Inventorship, and Ethics Sean inquires whether AI must be deemed sentient to own patents, to which Dr. Grazer cites legal precedent from the monkey selfie case restricting inventorship to humans. Sean playfully objects to human-exclusive copyright frameworks.36:33–39:46 · Guest disagreement 0/10 The Fundamentals of Patent Licensing and Business Agreements Sean asks about the mechanics of patent licensing and recent business lessons. Dr. Grazer clarifies that licensing agreements are commercial contracts governed by overarching business goals, sharing how COVID forced agile operational pivots.1:24–4:52 · Sean pushing back 0/10 We Live to Build Show Bumper and Mission Statement Sean introduces the podcast and asks Dr. Grazer about her background and the outcome of the Human Genome Project patent battles. Dr. Grazer explains how courts determined pure genetic material is unpatentable, educating Sean on biological IP law.4:53–7:38 · Sean pushing back 0/10 Defining Patents: Legal Monopolies, History, and Disclosure Requirements Sean asks foundational questions regarding what patents are and what types exist. Dr. Grazer delivers an informative breakdown of legal monopolies, historical guild secrecy, and utility versus design patents.7:38–12:53 · Sean pushing back 0/10 The Territorial Nature of Global Patents Sean inquires why there is no single international patent office and what the US filing workflow entails. Dr. Grazer walks through the territorial nature of patent treaties, patentability searches, claim drafting, and USPTO examiner negotiations.12:54–15:59 · Sean pushing back 0/10 DIY Filing vs. Professional Patent Agents: Costs, Risks, and Timelines Sean asks about the cost and timeline differences between self-filing and hiring a registered agent or attorney. Dr. Grazer highlights the precision of legal language, provisional applications, and the major financial and validity risks of DIY filing mistakes.15:59–19:10 · Sean pushing back 0/10 USPTO Examination Backlogs and Claim Strategy Sean asks about examination wait times and the pros and cons of patenting for startups. Dr. Grazer explains USPTO backlogs, uses a property fence analogy for claim scope, and notes that a pending patent application typically adds one million dollars to a startup valuation.19:11–21:59 · Sean pushing back 0/10 Strategic Business Applications of Patents and Channel Sales Defense Sean prompts Dr. Grazer to explain commercial drawbacks and optimal filing timelines. Dr. Grazer clarifies that US law offers a one-year post-publication grace period, whereas international jurisdictions require absolute novelty prior to public disclosure.21:59–25:22 · Sean pushing back 0/10 Understanding Patent Trolls, Non-Practicing Entities, and Injunction Limits Sean asks Dr. Grazer to define patent trolls and asks what key topics founders overlook. Dr. Grazer breaks down non-practicing entities and preliminary injunction legal standards, emphasizing why early proactive IP planning is critical.25:23–27:51 · Sean pushing back 0/10 KISS Platform and Agile Competitive Intelligence with iSearch.ai Sean asks about the unique selling proposition of Dr. Grazer's software tool iSearch.ai and KISS Platform. Dr. Grazer describes how the platform democratizes agile competitive intelligence and patent analysis for early-stage innovators.27:51–30:57 · Sean pushing back 0/10 Future of Intellectual Property: Patent Pools and FRAND Licensing Sean connects historical government origins with rapid modern technological shifts under Industry 4.0. Dr. Grazer responds by illustrating how modern patent pools and telecommunications FRAND licensing prevent market monopolization.30:57–32:57 · Sean pushing back 0/10 Open Source, Defensive Patent Pledges, and Industry Non-Aggression Sean asks if any industry has collectively boycotted patents. Dr. Grazer explains that while open-source licensing and corporate pledges like Tesla and Twitter exist, complete industry-wide non-aggression pacts remain largely non-existent.32:58–36:33 · Sean pushing back 1/10 Artificial Intelligence in Patent Law: Authorship, Inventorship, and Ethics Sean inquires whether AI must be deemed sentient to own patents, to which Dr. Grazer cites legal precedent from the monkey selfie case restricting inventorship to humans. Sean playfully objects to human-exclusive copyright frameworks.36:33–39:46 · Sean pushing back 0/10 The Fundamentals of Patent Licensing and Business Agreements Sean asks about the mechanics of patent licensing and recent business lessons. Dr. Grazer clarifies that licensing agreements are commercial contracts governed by overarching business goals, sharing how COVID forced agile operational pivots.

speaking balance: gold is Sean, purple is the guest (3 minute bins)

0:00 · Sean 78.1% · guest 21.9%0:00 · Sean 78.1% · guest 21.9%3:00 · Sean 14.4% · guest 85.6%3:00 · Sean 14.4% · guest 85.6%6:00 · Sean 12.1% · guest 87.9%6:00 · Sean 12.1% · guest 87.9%9:00 · Sean 7.8% · guest 92.2%9:00 · Sean 7.8% · guest 92.2%12:00 · Sean 5.8% · guest 94.2%12:00 · Sean 5.8% · guest 94.2%15:00 · Sean 10.6% · guest 89.4%15:00 · Sean 10.6% · guest 89.4%18:00 · Sean 11% · guest 89%18:00 · Sean 11% · guest 89%21:00 · Sean 5.5% · guest 94.5%21:00 · Sean 5.5% · guest 94.5%24:00 · Sean 7.3% · guest 92.7%24:00 · Sean 7.3% · guest 92.7%27:00 · Sean 17.3% · guest 82.7%27:00 · Sean 17.3% · guest 82.7%30:00 · Sean 5.4% · guest 94.6%30:00 · Sean 5.4% · guest 94.6%33:00 · Sean 16.5% · guest 83.5%33:00 · Sean 16.5% · guest 83.5%36:00 · Sean 11.7% · guest 88.3%36:00 · Sean 11.7% · guest 88.3%39:00 · Sean 27.5% · guest 72.5%39:00 · Sean 27.5% · guest 72.5%
Sharpest disagreement ▶ 35:37 Grazer grounds AI sentience speculation in human legal precedent

Dr. Grazer gently deflects Sean's philosophical question about AI sentience by steering the conversation back to existing case law requiring human authorship.

Hardest push from Sean ▶ 36:29 Sean challenges human-exclusive intellectual property rights

Sean humorously pushes back against the legal doctrine excluding non-human creators by calling human-only copyright laws speciesist.

Biggest teaching moment ▶ 20:42 Grazer highlights the critical US vs international publication rule

Dr. Grazer provides crucial legal distinction showing how public marketing triggers an immediate foreign patent bar while US law grants a one-year grace window.

Sean holds their own ▶ 27:51 Sean contextualizes patent systems against Industry 4.0 evolution

Sean synthesizes technological history from the Industrial Revolution through modern AI to question how bureaucratic state institutions can keep pace.

the scores for every segment, with the reasoning behind each
ChapterTopicSean as informed peerGuest teachingGuest disagreementSean pushing backWhy
We Live to Build Show Bumper and Mission Statement 2510 Sean introduces the podcast and asks Dr. Grazer about her background and the outcome of the Human Genome Project patent battles. Dr. Grazer explains how courts determined pure genetic material is unpatentable, educating Sean on biological IP law.
Defining Patents: Legal Monopolies, History, and Disclosure Requirements 1600 Sean asks foundational questions regarding what patents are and what types exist. Dr. Grazer delivers an informative breakdown of legal monopolies, historical guild secrecy, and utility versus design patents.
The Territorial Nature of Global Patents 1700 Sean inquires why there is no single international patent office and what the US filing workflow entails. Dr. Grazer walks through the territorial nature of patent treaties, patentability searches, claim drafting, and USPTO examiner negotiations.
DIY Filing vs. Professional Patent Agents: Costs, Risks, and Timelines 2700 Sean asks about the cost and timeline differences between self-filing and hiring a registered agent or attorney. Dr. Grazer highlights the precision of legal language, provisional applications, and the major financial and validity risks of DIY filing mistakes.
USPTO Examination Backlogs and Claim Strategy 2700 Sean asks about examination wait times and the pros and cons of patenting for startups. Dr. Grazer explains USPTO backlogs, uses a property fence analogy for claim scope, and notes that a pending patent application typically adds one million dollars to a startup valuation.
Strategic Business Applications of Patents and Channel Sales Defense 2700 Sean prompts Dr. Grazer to explain commercial drawbacks and optimal filing timelines. Dr. Grazer clarifies that US law offers a one-year post-publication grace period, whereas international jurisdictions require absolute novelty prior to public disclosure.
Understanding Patent Trolls, Non-Practicing Entities, and Injunction Limits 2600 Sean asks Dr. Grazer to define patent trolls and asks what key topics founders overlook. Dr. Grazer breaks down non-practicing entities and preliminary injunction legal standards, emphasizing why early proactive IP planning is critical.
KISS Platform and Agile Competitive Intelligence with iSearch.ai 2400 Sean asks about the unique selling proposition of Dr. Grazer's software tool iSearch.ai and KISS Platform. Dr. Grazer describes how the platform democratizes agile competitive intelligence and patent analysis for early-stage innovators.
Future of Intellectual Property: Patent Pools and FRAND Licensing 3700 Sean connects historical government origins with rapid modern technological shifts under Industry 4.0. Dr. Grazer responds by illustrating how modern patent pools and telecommunications FRAND licensing prevent market monopolization.
Open Source, Defensive Patent Pledges, and Industry Non-Aggression 3610 Sean asks if any industry has collectively boycotted patents. Dr. Grazer explains that while open-source licensing and corporate pledges like Tesla and Twitter exist, complete industry-wide non-aggression pacts remain largely non-existent.
Artificial Intelligence in Patent Law: Authorship, Inventorship, and Ethics 3611 Sean inquires whether AI must be deemed sentient to own patents, to which Dr. Grazer cites legal precedent from the monkey selfie case restricting inventorship to humans. Sean playfully objects to human-exclusive copyright frameworks.
The Fundamentals of Patent Licensing and Business Agreements 2500 Sean asks about the mechanics of patent licensing and recent business lessons. Dr. Grazer clarifies that licensing agreements are commercial contracts governed by overarching business goals, sharing how COVID forced agile operational pivots.

Statements from this episode (21)

Assertion Contradicted
Grazer: Several Craig Venter genome patents were ultimately ruled invalid
“Indeed a number of the patents that Craig Venter got were finally held not to be valid”
Dr. Devorah Grazer Jan 28, 2021 ▶ 3:21
Assertion Supported
US law forbids patenting pure genetic material without human manipulation
“So ultimately in the U S it was held that these genes could not be patented. That pure genetic material was not itself Patentable. Only if it was manipulated by humans, for example, for use in making special proteins, could it actually be patentable?”
Dr. Devorah Grazer Jan 28, 2021 ▶ 3:59
Assertion Contradicted
Grazer: Patents are the only legal monopoly outside regulated utilities
“Patents are the only legally permitted monopoly right outside of, say, highly regulated utilities.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 5:03
Assertion Contradicted
Grazer: Specialized Banks Issue Tech Loans Backed by Patents
“There are even special banks set up that do nothing but give loans to high tech companies on the basis of their patents.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 7:33
Assertion Supported
Anyone can file US, European, or Chinese patents without local ties
“Innovators all over the world can get a patent in the US. You don't have to be a US citizen. You don't have to have a US company. You don't have to have any US ties. Similarly, anyone who, even if they don't live in Europe or have a European tie, can get a pat…”
Dr. Devorah Grazer Jan 28, 2021 ▶ 8:25
Insight
Grazer recommends 7 to 10 drawings for software and hardware patents
“For example, for software hardware drawings, I recommend that the innovator would have at least seven to 10 drawings. It's a good rule of thumb to make sure you really explain your idea.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 10:22
Assertion Supported
Grazer: Inventors do not need a working prototype to secure a patent
“You don't actually need to have ever built your idea before you get a granted patent. You can actually just have a really good design, and it has happened that there are innovators who have come up with great ideas, but who haven't managed to make a commercial…”
Dr. Devorah Grazer Jan 28, 2021 ▶ 12:33
Insight
Drafting an initial patent with an agent takes six to eight weeks
“Doing it with a patent attorney or agent, typically you're looking at six weeks to two months. Could be a bit longer if you realize in the middle that you need to rework the idea.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 14:33
Assertion Supported
Grazer: Initial Patent Applications at Top Firms Can Cost Up to $20,000
“If you go to a fancy firm, you can spend up to 20,000 dollars for the initial application, depending on how much extra work you do with them.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 15:02
Assertion Partly supported
Grazer: USPTO first responses take 1.5 to 4 years
“Typically now I'm seeing it takes one and a half to two years, or even three or four years before you get the first reaction from the examiner.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 16:13
Assertion Not checkable as stated
Grazer: Filing a patent application typically adds $1M to startup valuation
“Typically filing for a patent application, even before it's granted as an, you know, before it becomes an issue, patent will add a million dollars to the valuation of a startup.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 17:41
Assertion Contradicted
Grazer: Facebook had to buy patents before its IPO at bankers' insistence
“Facebook actually had to buy more patents before its IPO, because the investment bankers handling the IPO said, you don't have enough patents. This will make it hard for us to do the IPO because patent pending represents potential.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 18:20
Insight
Grazer: NDAs are hard to defend in court compared to patents
“I mean, NDAs, non-disclosure agreements are great, but they're very hard to defend in court. Whereas a patent is an absolute right, and it can be super helpful, especially when dealing with a bigger competitor.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 20:24
Assertion Supported
US Patent Law Allows a One-Year Grace Period Post-Publication
“So in the U S you're allowed to file for a patent within one year of publishing your idea.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 20:45
Assertion Partly supported
International Patent Filings Require Filing Before Any Public Disclosure
“Outside the U S You are only allowed to file for a patent if you do so before you publish.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 21:05
Assertion Supported
Grazer: US Courts Deny Preliminary Injunctions to Non-Practicing Patent Entities
“In the U S the patent trolls are the knows knows the MPEs and non-practicing entities. Their power has been reduced somewhat because now in order to get a preliminary injunction, so that is when, let's say I accuse you, Sean, of patent infringement, not to go …”
Dr. Devorah Grazer Jan 28, 2021 ▶ 22:55
Assertion Supported
Grazer: Jack Dorsey founded a blockchain patent pool to curb monopolies
“So for example, Jack Dorsey, CEO of Twitter, who's also CEO of Square, has recently founded a new patent pool in blockchain, and he's encouraging others to put blockchain patents in, in order to keep large companies from monopolizing the space.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 29:31
Prediction Not checkable as stated
Grazer: More patent pools and FRAND agreements will emerge by 2031
“So in my opinion, in the next 10 years, we'll see more patent pools, more Patent agreements come up that will allow for such fair and reasonable licensing agreements.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 30:39
Assertion Supported
Grazer: Companies like Twitter and Tesla pledged purely defensive patent enforcement
“Some companies have decided on their own that they will only enforce their patents if someone attacks them first. So Twitter has pledged this Elon Musk in a famous blog post with the title, all our patents are belong to you playing off of the famous meme, all …”
Dr. Devorah Grazer Jan 28, 2021 ▶ 31:52
Prediction Not checkable as stated
Grazer: AI industry will not agree on a single patent standard
“Now, it could very well be that folks will reach agreements in particular industries. I have a hard time seeing that the entire AI industry and all these different verticals will come to a single agreement.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 35:00
Assertion Supported
Grazer: Patent law currently recognizes only human persons as inventors
“Right now, an inventor is considered to be a person.”
Dr. Devorah Grazer Jan 28, 2021 ▶ 35:47
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 300 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.